CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 37 filers reported holding CERULEAN PHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $677,000 | -20.2% | 319,289 | +2.1% | 0.01% | -25.0% |
| Q1 2016 | $848,000 | -0.1% | 312,809 | +3.2% | 0.01% | -11.1% |
| Q4 2015 | $849,000 | -18.4% | 303,139 | +6.6% | 0.01% | -25.0% |
| Q3 2015 | $1,041,000 | -57.0% | 284,501 | -46.0% | 0.01% | -14.3% |
| Q2 2015 | $2,422,000 | – | 526,648 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,437,441 | $5,261,000 | 9.25% |
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $12,032,000 | 8.20% |
| Deer VII & Co. Ltd. | 166,675 | $610,000 | 0.58% |
| WALL STREET ASSOCIATES | 475,000 | $1,738,000 | 0.33% |
| Cormorant Asset Management, LP | 551,354 | $2,018,000 | 0.32% |
| Rock Springs Capital Management LP | 625,000 | $2,288,000 | 0.19% |
| Northeast Financial Consultants Inc | 40,000 | $146,000 | 0.07% |
| Granahan Investment Management | 377,277 | $1,381,000 | 0.04% |
| Donald L. Hagan, LLC | 10,000 | $37,000 | 0.03% |
| Alyeska Investment Group, L.P. | 284,501 | $1,041,000 | 0.01% |